{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:50:35Z","timestamp":1760547035934},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":6825,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2001,5]]},"DOI":"10.1023\/a:1011136807190","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T06:26:45Z","timestamp":1040624805000},"page":"693-699","source":"Crossref","is-referenced-by-count":31,"title":["High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumour Registry of the European Group for Blood and Marrow Transplantation (EBMT)"],"prefix":"10.1016","volume":"12","author":[{"given":"J.A.","family":"Ledermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Herd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Maraninchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Viens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Buclon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Philip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Cure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Lotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Chauvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ferrante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rosti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1023\/A:1011136807190_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199601043340101","article-title":"Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer","volume":"334","author":"McGuire","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1023\/A:1011136807190_bb0015","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin\u2013paclitaxel versus cisplatin\u2013cyclophosphamide in women with advanced epithelial ovarian cancer: Three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011136807190_bb0020","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/0277-5379(91)90011-2","article-title":"Long term survival in ovarian cancer: Mature data from The Netherlands Joint Study Group for Ovarian Cancer","volume":"27","author":"Neijt","year":"1991","journal-title":"Eur J Cancer"},{"key":"10.1023\/A:1011136807190_bb0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1136\/bmj.303.6807.884","article-title":"Chemotherapy in advanced ovarian cancer. An overview of randomised clinical trials","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1023\/A:1011136807190_bb0030","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/JCO.1987.5.5.756","article-title":"Dose intensity analysis of chemotherapy regimens in ovarian carcinoma","volume":"5","author":"Levin","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0035","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/jnci\/85.21.1732","article-title":"Importance of multiagent chemotherapy regimens in ovarian carcinoma Dose intensity analysis","volume":"85","author":"Levin","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1023\/A:1011136807190_bb0040","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.1997.15.4.1291","article-title":"Dose-intensity in ovarian carcinoma. Hold, enough?","volume":"15","author":"Thigpen","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0045","series-title":"Cancer of the Ovary","first-page":"327","article-title":"High-dose chemotherapy with autologous bone marrow support for the treatment of epithelial ovarian cancer","author":"Shpall","year":"1993"},{"key":"10.1023\/A:1011136807190_bb0050","first-page":"227","article-title":"High dose melphalan and autologous marrow rescue in advanced epithelial ovarian carcinomas: A retrospective analysis of 35 patients treated in France","volume":"5","author":"Viens","year":"1990","journal-title":"Bone Marrow Transplant"},{"key":"10.1023\/A:1011136807190_bb0055","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1200\/JCO.1991.9.10.1860","article-title":"Phase I\u2013II study of two consecutive courses of high-dose epipodophyllotoxin, ifosfamide, and carboplatin with autologous bone marrow transplantation for treatment of adult patients with solid tumors","volume":"9","author":"Lotz","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0060","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/07853899509031949","article-title":"High-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer","volume":"27","author":"Benedetti-Panici","year":"1995","journal-title":"Ann Med"},{"key":"10.1023\/A:1011136807190_bb0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1995.1143","article-title":"A phase II trial of high-dose mitoxantrone, carboplatin, and cyclophosphamide with autologous bone marrow rescue for recurrent epithelial ovarian carcinoma: Analysis of risk factors for clinical outcome","volume":"57","author":"Stiff","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1023\/A:1011136807190_bb0070","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1200\/JCO.1997.15.4.1302","article-title":"High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results","volume":"15","author":"Legros","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0075","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.1995.13.5.1160","article-title":"Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin\/cyclophosphamide courses","volume":"13","author":"Fennelly","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0080","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1200\/JCO.1997.15.4.1309","article-title":"High-dose chemotherapy with autologous transplantation for persistent\/relapsed ovarian cancer. A multivanate analysis of survival for 100 consecutively treated patients","volume":"15","author":"Stiff","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0085","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/bjc.1990.315","article-title":"Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG))","volume":"62","author":"Marsoni","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1023\/A:1011136807190_bb0090","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1008211203563","article-title":"How many more nails to seal the coffin of dose intensity?","volume":"8","author":"McGuire","year":"1997","journal-title":"Ann Oncol"},{"key":"10.1023\/A:1011136807190_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1983.1.6.359","article-title":"Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer","volume":"1","author":"Lazarus","year":"1983","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0100","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1200\/JCO.1989.7.5.651","article-title":"A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support","volume":"7","author":"Shea","year":"1989","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1200\/JCO.1994.12.1.37","article-title":"Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study","volume":"12","author":"Ayash","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0110","first-page":"360","article-title":"High dose chemotherapy in ovarian cancer: An analysis of the experience of the European Group for Blood and Marrow Transplant (EBMT) over 7 years","volume":"18","author":"Ledermann","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1023\/A:1011136807190_bb0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7326\/0003-4819-133-7-200010030-00009","article-title":"High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: An autologous blood and marrow transplant registry report","volume":"133","author":"Stiff","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1023\/A:1011136807190_bb0120","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/sj.bmt.1701659","article-title":"Sequential cycles of high-dose chemotherapy with dose escalation of carboplatin with or without paclitaxel supported by G-CSF mobilized peripheral blood progenitor cells A phase I\/II study in advanced ovarian cancer","volume":"23","author":"Wandt","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1023\/A:1011136807190_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.bmt.1701089","article-title":"Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders. Current practice in Europe in 1998. Accreditation Sub-Committee of the European Group for Blood and Marrow Transplantation","volume":"21","author":"Goldman","year":"1998","journal-title":"Bone Marrow Transplant"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419541254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419541254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/12\/5\/693\/19479289\/12-5-693.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T02:04:14Z","timestamp":1582164254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419541254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["S0923753419541254"],"URL":"https:\/\/doi.org\/10.1023\/a:1011136807190","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2001,5]]}}}